Chou Judy - 12 Jul 2021 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Director
Signature
/s/ Jonathan Young, attorney-in-fact
Issuer symbol
AKRO
Transactions as of
12 Jul 2021
Net transactions value
$0
Form type
4
Filing time
14 Jul 2021, 16:09:13 UTC
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKRO Stock Option (Right to Buy) Award $0 -26,000 -50% $0.000000 26,000 12 Jul 2021 Common Stock 26,000 $24.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in 36 equal monthly installments, commencing on July 12, 2021.